BIO Key Company Top Insiders
BKYI Stock | USD 1.06 0.05 4.95% |
BIO Key's insiders are aggressively buying. The analysis of insider sentiment suggests that almost all BIO Key International insiders are, at present, extremely bullish. BIO Key employs about 43 people. The company is managed by 9 executives with a total tenure of roughly 60 years, averaging almost 6.0 years of service per executive, having 4.78 employees per reported executive.
Kwok Wong Chairman MD ViceChairman |
Michael DePasquale Chairman Chairman, CEO and Pres |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
2023-11-30 | James David Sullivan | Acquired 1111 @ 3.06 | View | ||
2023-11-27 | James David Sullivan | Acquired 555 @ 2.88 | View | ||
2023-11-24 | James David Sullivan | Acquired 1648 @ 2.88 | View | ||
2023-10-30 | Michael W Depasquale | Acquired 9166 @ 3.06 | View | ||
2022-06-14 | Michael W Depasquale | Acquired 111 @ 29.88 | View | ||
2022-05-26 | Michael W Depasquale | Acquired 138 @ 32.4 | View |
Monitoring BIO Key's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
BIO |
BIO Key Management Team Effectiveness
The company has return on total asset (ROA) of (0.5568) % which means that it has lost $0.5568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5811) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -2.59. The BIO Key's current Return On Capital Employed is estimated to increase to -7.4. As of now, BIO Key's Net Tangible Assets are increasing as compared to previous years. The BIO Key's current Intangibles To Total Assets is estimated to increase to 0.37, while Non Current Assets Total are projected to decrease to under 2.1 M.The current Common Stock Shares Outstanding is estimated to decrease to about 391 K. The current Net Loss is estimated to decrease to about (4.8 M)
BIO Key Workforce Comparison
BIO Key International is number one stock in number of employees category among its peers. The total workforce of Information Technology industry is currently estimated at about 32,866. BIO Key adds roughly 43.0 in number of employees claiming only tiny portion of equities under Information Technology industry.
The company has Profit Margin (PM) of (0.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.45. BIO Key Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIO Key insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
James Sullivan six days ago Acquisition by James Sullivan of 1 shares of BIO Key at 1.4 subject to Rule 16b-3 | ||
James Sullivan over a month ago Acquisition by James Sullivan of 2377 shares of BIO Key at 1.52 subject to Rule 16b-3 | ||
Knook Pieter Cornelis over a month ago Acquisition by Knook Pieter Cornelis of 1429 shares of BIO Key subject to Rule 16b-3 | ||
Michel Robert J over a month ago Acquisition by Michel Robert J of 1429 shares of BIO Key subject to Rule 16b-3 | ||
James Sullivan over two months ago Acquisition by James Sullivan of 1 shares of BIO Key at 1.4 subject to Rule 16b-3 | ||
Fiber Food Systems, Inc. over three months ago Insider Trading | ||
Alia Emmanuel over three months ago Acquisition by Alia Emmanuel of 2587 shares of BIO Key subject to Rule 16b-3 | ||
Michel Robert J over six months ago Acquisition by Michel Robert J of 1429 shares of BIO Key subject to Rule 16b-3 |
BIO Key Notable Stakeholders
A BIO Key stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIO Key often face trade-offs trying to please all of them. BIO Key's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIO Key's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kwok Wong | MD ViceChairman | Profile | |
Michael DePasquale | Chairman, CEO and Pres | Profile | |
Mark Cochran | President PortalGuard | Profile | |
Cecilia Welch | Chief Officer | Profile | |
Akintunde Jeje | Managing Africa | Profile | |
Alex Rocha | Managing EMEA | Profile | |
Mira LaCous | Chief Officer | Profile | |
Frederick Corsentino | Chief Revenue Officer | Profile | |
James Sullivan | Senior Officer | Profile |
About BIO Key Management Performance
The success or failure of an entity such as BIO Key International often depends on how effective the management is. BIO Key management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIO management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIO management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.47) | (2.59) | |
Return On Capital Employed | (7.79) | (7.40) | |
Return On Assets | (1.70) | (1.78) | |
Return On Equity | (9.21) | (8.75) |
BIO Key Workforce Analysis
Traditionally, organizations such as BIO Key use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIO Key within its industry.BIO Key Manpower Efficiency
Return on BIO Key Manpower
Revenue Per Employee | 180.3K | |
Revenue Per Executive | 861.7K | |
Net Loss Per Employee | 198.2K | |
Net Loss Per Executive | 946.9K |
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |